Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Agenix
Positive results reported in trial of imaging device for pulmonary embolism diagnosis
April 8th, 2006
Agenix has completed a phase 1b pulmonary embolism (PE - blood clot in the lung) trial in Australia in a comparative study against computed tomography pulmonary angiography (CTPA) demonstrating that ThromboView has the potential to be highly beneficial in the diagnosis of PE. Images acquired in this safety study, which evaluated 14 patients, all positive for PE by CTPA diagnosis, demonstrated high concordance between ThromboView images and CTPA findings. As part of this study, an analysis was performed by independent nuclear medicine specialists who were unaware of the detailed CTPA findings. This independent analysis confirmed a higher than expected sensitivity of...
Source: Law & Health Weekly (2006-04-08)
|
